Latest Distributions News

Bubs Australia has reported a strong Q2 FY25 performance with a positive EBITDA turnaround and robust revenue growth, while advancing its critical FDA clinical trial in the US.

LTR Pharma has inked a national distribution agreement with Symbion, positioning its innovative ED treatment SPONTAN® for broad pharmacy access across Australia ahead of its commercial launch.

First Graphene Limited strengthens its financial footing with a UK R&D tax rebate and expands its global footprint through new distribution agreements in India and Brazil.

Clime Capital Limited has updated its dividend announcement, confirming a fully franked ordinary dividend of AUD 0.0135 per share and setting the Dividend Reinvestment Plan (DRP) issue price at AUD 0.7824.

Alternative Investment Trust (ASX: AIQ) has announced a special unfranked dividend of AUD 0.04186 per unit, representing a full return of capital to investors, payable in February 2025.

Leo Lithium Limited has announced a total distribution of 17.2 cents per share, combining a capital return and a special dividend, payable at the end of January 2025.

LEO Lithium Limited has confirmed the precise details of its special dividend, finalizing a total distribution of 17.2 cents per share following shareholder approval for a return of capital component.

BKI Investment Company Limited has announced a fully franked ordinary dividend of AUD 0.039 per share for the half-year ending December 31, 2024, payable on February 28, 2025. The company’s Dividend Reinvestment Plan remains active, offering shareholders flexibility.

Charter Hall Wholesale Management Limited has secured majority control of Hotel Property Investments (HPI) with a 63.7% voting stake and the HPI board now recommends acceptance of the all-cash takeover offer valued at $3.752 per security.

Wellnex Life has negotiated a delayed and reduced-cost payment arrangement for its Pain Away acquisition, aligning with its upcoming London Stock Exchange dual listing plans. The move supports the company’s growth momentum following record revenues from Pain Away.

Hazer Group has successfully completed its Commercial Demonstration Plant program ahead of schedule, validating its methane pyrolysis technology and securing significant funding to accelerate commercialisation in 2025.

Brazilian Critical Minerals Limited reports strong assay results from its 2024 drilling program at the Ema project, confirming widespread high-grade rare earth mineralisation ideal for in-situ recovery mining.